TY - JOUR
T1 - Expression of p16 and p53 in intraepithelial periocular sebaceous carcinoma
AU - Bell, W. Robert
AU - Singh, Kamaljeet
AU - Anand Rajan, K. D.
AU - Eberhart, Charles G.
N1 - Publisher Copyright:
© 2015 S. Karger AG, Basel.
PY - 2016
Y1 - 2016
N2 - Purpose: Identifying intraepithelial sebaceous carcinoma cells in small periocular biopsies can be difficult, particularly in the conjunctiva. The goal of this study was to evaluate p53 and p16 immunohistochemistry as potential markers of intraepithelial sebaceous carcinoma. Procedures: A total of 25 tumors, including 4 recurrent lesions, were stained for p16 and p53, with intensity scored as negative, weak, moderate or strong. Results: Expression of p16 was detected in intraepithelial sebaceous carcinoma cells in 24 of the 25 cases (96%), with only 1 case showing weak immunoreactivity. Intraepithelial p53 immunoreactivity was present in 17 of 25 tumors (68%), but was weak in 3 cases. Expression levels remained relatively stable in primary and recurrent tumors, but varied in a few cases between intraepithelial and subepithelial sites. Conclusions: Intraepithelial sebaceous carcinomas stained for p53 and p16 demonstrated moderate to strong immunoreactivity in 100% of cases for at least one of these proteins, suggesting that together they are useful markers for determining the extent of tumor spread. Of the two, p16 was immunoreactive in more cases than p53.
AB - Purpose: Identifying intraepithelial sebaceous carcinoma cells in small periocular biopsies can be difficult, particularly in the conjunctiva. The goal of this study was to evaluate p53 and p16 immunohistochemistry as potential markers of intraepithelial sebaceous carcinoma. Procedures: A total of 25 tumors, including 4 recurrent lesions, were stained for p16 and p53, with intensity scored as negative, weak, moderate or strong. Results: Expression of p16 was detected in intraepithelial sebaceous carcinoma cells in 24 of the 25 cases (96%), with only 1 case showing weak immunoreactivity. Intraepithelial p53 immunoreactivity was present in 17 of 25 tumors (68%), but was weak in 3 cases. Expression levels remained relatively stable in primary and recurrent tumors, but varied in a few cases between intraepithelial and subepithelial sites. Conclusions: Intraepithelial sebaceous carcinomas stained for p53 and p16 demonstrated moderate to strong immunoreactivity in 100% of cases for at least one of these proteins, suggesting that together they are useful markers for determining the extent of tumor spread. Of the two, p16 was immunoreactive in more cases than p53.
KW - Intraepithelial spread
KW - Sebaceous carcinoma
KW - p16 immunohistochemistry
KW - p53 immunohistochemistry
UR - http://www.scopus.com/inward/record.url?scp=84986626272&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84986626272&partnerID=8YFLogxK
U2 - 10.1159/000439308
DO - 10.1159/000439308
M3 - Article
AN - SCOPUS:84986626272
SN - 2296-4681
VL - 2
SP - 71
EP - 75
JO - Ocular Oncology and Pathology
JF - Ocular Oncology and Pathology
IS - 2
ER -